Florey Institute awarded $494,000 to advance groundbreaking “FeBI” quantum iron test
Posted: 26 August 2025 The Florey Institute announced it had received $494,000 from the Federal Government to progress a groundbreaking quantum-based blood test, FeBI, developed with the University of Melbourne to measure iron levels cheaply, reliably and accurately.…
La Trobe University opens biosensor research hub following $4.7 million grant
Posted: 19 August 2025 La Trobe University has unveiled a new biosensor research hub aimed at developing devices that can detect molecules in food, air, or blood, including allergen tests. The facility, named the Australian Research Council Research…
Noxopharm advances HERACLES clinical trial with second dose cohort completion
Posted: 14 August 2025 Noxopharm Limited is has announced the second dose cohort of SOF-SKN™ has been successfully completed in the HERACLES trial. The safety steering committee has determined the second dose level to be safe and tolerable,…
VivaZome publishes landmark review on customised Extracellular Vesicles (EVs)
Posted: 11 August 2025 VivaZome Therapeutics has published a major review artcile in Health Nanotechnology, titled “Customised extracellular vesicle therapeutics for neurological conditions.” The paper was authored by Dr Ella Johnston, with co-authors Johannes Weber, Xenia Sango (CEO),…
Cartherics unveils state-of-the-art cleanroom facility for cell therapy manufacturing
Posted: 11 August 2025 Cartherics Pty Ltd officially opened its new state-of-the-art cleanroom facility in Notting Hill, Victoria, marking a significant milestone in the company’s mission to advance off-the-shelf immune stem cell therapies for women’s health. The facility…
BioNTech clinical trial platform launched at Peter Mac to expand cancer patient access across Victoria
Posted: 6 August 2025 BioNTech has officially launched a new Clinical Trial Oncology Platform in partnership with the Peter MacCallum Cancer Centre, aimed at expanding access to investigational cancer treatments across Victoria. The initiative, backed by the Allan…
Cell Therapies and VVMF enter strategic collaboration to strengthen Australia’s development and manufacturing of advanced therapy medicinal products
Posted: 4 August 2025 Cell Therapies Pty Ltd and Viral Vector Manufacturing Facility Pty Ltd (VVMF) formalised a strategic collaboration through a memorandum of understanding (MoU) aimed at enhancing the domestic development and manufacturing of Advanced Therapy Medicinal…
Planet Innovation forms strategic alliance with Meiban to deliver integrated CDMO Services
Posted: 4 August 2025 Meiban Corp Holdings has entered into a strategic alliance with Planet Innovation (PI) to deliver end-to-end Contract Development and Manufacturing Organization (CDMO) services for the MedTech sector. The collaboration was designed to streamline the…
NRFC allocates $150 million to partner with Brandon Capital and advance Australian medical innovation
Posted: 4 August 2025 The National Reconstruction Fund Corporation (NRFC) has committed $150 million to Brandon Capital’s Brandon BioCatalyst 6 (BB6) fund, furthering efforts to develop and commercialise Australian-made therapeutics, medical devices, and vaccines. The recenly announced funding…
Brandon Capital secures over $430M in final close of sixth life sciences investment fund
Posted: 4 August 2025 Australian life sciences venture capital firm Brandon Capital confirmed the final close of its sixth fund- Brandon BioCatalyst Fund 6, exceeding $430 million AUD in commitments. This marked one of the largest life sciences venture…
RMIT University unveils wearable device that heals “remotely”
Posted: 4 August 2025 Researchers from RMIT University have developed a wearable wound monitoring device with sensors that could reduce infection risks by minimising the need for frequent physical contact, healing remotely via a Bluetooth connection. Conventional wound…
Chubb celebrates 20-year anniversary and launches new premier insurance package
Posted: 4 August 2025 Coinciding with their 20-year anniversary, Chubb has launched a new insurance package – Premier Life Science – developed to meet the evolving risk landscape facing companies in the life sciences sector. The tailored package…
